🇺🇸 VS-6063 in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 4
Most-reported reactions
- Abdominal Pain — 1 report (25%)
- Confusional State — 1 report (25%)
- Constipation — 1 report (25%)
- Nausea — 1 report (25%)
Frequently asked questions
Is VS-6063 approved in United States?
VS-6063 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for VS-6063 in United States?
Verastem, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.